Apellis Pharmaceuticals (NasdaqGS:APLS) FY 2025 Conference December 02, 2025 02:30 PM ET Company ParticipantsCedric Francois - CEOTim Sullivan - CFOConference Call ParticipantsYigal Nochomovitz - AnalystYigal NochomovitzOkay. Ready to go. All right. So, Apellis, welcome. Great to see you. So, of course, we have Cedric Francois, CEO and also the co-founder and president of the company, and Tim Sullivan, CFO. So, welcome for those listening on the webcast and then in person. I'm Yigal Nochomovitz, biotech ana ...

Apellis Pharmaceuticals (NasdaqGS:APLS) FY 2025 Conference December 02, 2025 02:30 PM ET Company ParticipantsCedric Francois - CEOTim Sullivan - CFOConference Call ParticipantsYigal Nochomovitz - AnalystYigal NochomovitzOkay. Ready to go. All right. So, Apellis, welcome. Great to see you. So, of course, we have Cedric Francois, CEO and also the co-founder and president of the company, and Tim Sullivan, CFO. So, welcome for those listening on the webcast and then in person. I'm Yigal Nochomovitz, biotech ana ...

Apellis Pharmaceuticals (NasdaqGS:APLS) FY 2025 Conference December 02, 2025 02:30 PM ET Speaker1Okay. Ready to go. All right. So, Apellis, welcome. Great to see you. So, of course, we have Cedric Francois, CEO and also the co-founder and president of the company, and Tim Sullivan, CFO. So, welcome for those listening on the webcast and then in person. I'm Yigal Nachamovitz, biotech analyst at Citi. Been covering Apellis since the very beginning, a long time. So, it's great to be continuing to follow the st ...